India to Venezuela: Trastuzumab Export Trade Route

The India to Venezuela Trastuzumab corridor is one of India's established pharmaceutical export routes, with 13 shipments documented worth a combined $2.3M USD. The route is dominated by MEDWISE OVERSEAS PRIVATE LIMITED, which alone accounts for roughly 27% of all export value, reflecting the consolidated nature of India's trastuzumab manufacturing sector.

Across 10 active suppliers, the average shipment value stands at $177.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with trastuzumab's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 23.4%, placing it at rank #10 among India's top trastuzumab export destinations globally.

On the import side, key buyers of Indian trastuzumab in Venezuela include TO MEDICAMENTOS CONSUMOSASIA CA, TO THE ORDER OF. , TO THE ORDER OF PURCHASE MANAGER OF and 7 others. TO MEDICAMENTOS CONSUMOSASIA CA is the single largest importer with 1 shipments valued at $625.7K USD.

India's trastuzumab exports to Venezuela are driven primarily by a handful of large-scale manufacturers. MEDWISE OVERSEAS PRIVATE LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in Venezuela benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MEDWISE OVERSEAS PRIVATE LIMITED, SAMEEKSHA PHARMACEUTICALS PRIVATE LIMITED , AXA PARENTERALS LIMITED — together account for 77% of total trade value on this route. The average shipment value of $177.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as canmab 440-trastuzumab 440 mg injection and trastuzumab440 mg iny trasturel 440 mg bt no tmv1b23b03 mfg dt jan 23 exp dt dec 25, suggesting that buyers in Venezuela tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO MEDICAMENTOS CONSUMOSASIA CA is the largest importer with 1 shipments worth $625.7K USD — representing 27% of all trastuzumab imports from India on this route. A total of 10 buyers are active on this corridor.